- Home
- ULBI vs TLSI Comparison
ULBI vs TLSI Comparison
Compare ULBI & TLSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ULBI
- TLSI
- Stock Information
- Founded
- ULBI 1990
- TLSI 2010
- Country
- ULBI United States
- TLSI United States
- Employees
- ULBI N/A
- TLSI N/A
- Industry
- ULBI Industrial Machinery/Components
- TLSI Medical Specialities
- Sector
- ULBI Miscellaneous
- TLSI Health Care
- Exchange
- ULBI Nasdaq
- TLSI Nasdaq
- Market Cap
- ULBI 174.9M
- TLSI 166.8M
- IPO Year
- ULBI 1992
- TLSI N/A
- Fundamental
- Price
- ULBI $9.45
- TLSI $4.98
- Analyst Decision
- ULBI Strong Buy
- TLSI Strong Buy
- Analyst Count
- ULBI 1
- TLSI 3
- Target Price
- ULBI $14.00
- TLSI $12.67
- AVG Volume (30 Days)
- ULBI 43.7K
- TLSI 77.7K
- Earning Date
- ULBI 10-24-2024
- TLSI 11-12-2024
- Dividend Yield
- ULBI N/A
- TLSI N/A
- EPS Growth
- ULBI 283.01
- TLSI N/A
- EPS
- ULBI 0.60
- TLSI N/A
- Revenue
- ULBI $168,946,000.00
- TLSI $24,736,000.00
- Revenue This Year
- ULBI $10.59
- TLSI $61.24
- Revenue Next Year
- ULBI $8.72
- TLSI $47.32
- P/E Ratio
- ULBI $15.90
- TLSI N/A
- Revenue Growth
- ULBI 17.37
- TLSI 67.75
- 52 Week Low
- ULBI $6.36
- TLSI $3.32
- 52 Week High
- ULBI $13.39
- TLSI $10.42
- Technical
- Relative Strength Index (RSI)
- ULBI 40.08
- TLSI 35.99
- Support Level
- ULBI $9.24
- TLSI $4.43
- Resistance Level
- ULBI $9.69
- TLSI $5.32
- Average True Range (ATR)
- ULBI 0.37
- TLSI 0.34
- MACD
- ULBI -0.04
- TLSI -0.04
- Stochastic Oscillator
- ULBI 18.95
- TLSI 19.51
About ULBI Ultralife Corporation
Ultralife Corp provides products and services ranging from power solutions to communications and electronics systems to customers across the globe in the government and defense, medical, safety and security, energy, and industrial sectors. The company designs, manufactures, installs, and maintains power and communications systems including rechargeable and non-rechargeable batteries, charging systems, communications and electronics systems and accessories, and custom-engineered systems. The company's segments include Battery and Energy Products, and Communications Systems. It generates maximum revenue from the Battery and Energy Products segment, and from the U.S. The Battery & Energy Products segment includes Lithium 9-volt, cylindrical, and various other non-rechargeable batteries.
About TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of innovative drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product lines Pressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.